The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology.
Kevin R. Loughlin Imprint: Elsevier - Health Sciences Division Country of Publication: United States Edition: UK ed. Volume: 43-1 ISBN: 9780323417181 ISBN 10: 0323417183 Series:The Clinics: Internal Medicine Publication Date: 28 February 2016 Audience:
Professional and scholarly
Format: Hardback Publisher's Status: Active